experiment,contrast,cell_line,drug,dose,time_hr,morphology,tissue,disease,drug2
PRJNA316529,deazaneplanocinA,HL-60,3-deazaneplanocin A,1000nM,72,promyeloblast,blood,acute promyelocytic leukemia,other
PRJNA391270,a549_4gy,A459,4GY,NA,3,epithelial,lung,Carcinoma,other
PRJNA391270,a498_4gy,A498,4GY,NA,3,epithelial,kidney,Carcinoma,other
PRJNA391270,gy4.3hr,Cancer,4GY,NA,3,epithelial,lung,Carcinoma,other
PRJNA391270,h460_4gy,H460,4GY,NA,3,epithelial,lung,Carcinoma,other
PRJNA391270,hct116_4gy,HCT116,4GY,NA,3,epithelial,large intestine; colon,Carcinoma; Colorectal,other
PRJNA391270,lox_4gy,LOXIMVI,4GY,NA,3,epithelial,skin,Malignant Melanoma,other
PRJNA391270,malme3_4gy,MALME3M,4GY,NA,3,fibroblast,skin,Malignant Melanoma,other
PRJNA391270,skmel5_4gy,SKMEL5,4GY,NA,3,melanocyte,skin,Malignant Melanoma,other
PRJNA391270,u2os_4gy,U2OS,4GY,NA,3,epithelial,bone,Osteosarcoma,other
PRJNA391270,uacc257_4gy,UACC257,4GY,NA,3,epithelial,skin,Malignant Melanoma,other
PRJNA391270,uo31_4gy,UO31,4GY,NA,3,epithelial,kidney,Carcinoma,other
PRJNA391270,mcf7_4gy,MCF7,4GY + Decitabine,2uM,3,epithelial,breast,Adenocarcinoma,other
PRJNA417314,hc29_5fu,HT-29,5-FU,20uM,72,epithelial,large intestine; colon,Adenocarcinoma,other
PRJNA603369,abbv075.100nM,AML,ABBV-075,100nM,24,primary human cells,blood,Acute myeloid leukemia,other
PRJNA603369,kasumi.abbv075.100nM,Kasumi-1,ABBV-075,100nM,24,myeloblast,blood,Acute myeloblastic leukemia,other
PRJNA603369,mv411.abbv075.100nM,MV-4-11,ABBV-075,100nM,24,lymphoblast,blood,Biphenotypic B Myelomonocytic Leukemia,other
PRJNA603369,nci_h1299.abbv075.100nM,NCI-H1299,ABBV-075,100nM,24,epithelial,lung,Carcinoma,other
PRJNA603369,skm.abbv075.100nM,SKM-1,ABBV-075,100nM,24,myeloblast,blood,Acute myeloid leukemia,other
PRJNA603369,abbv744.200nM,AML,ABBV-744,200nM,24,primary human cells,blood,Acute myeloid leukemia,other
PRJNA603369,kasumi.abbv744.200nM,Kasumi-1,ABBV-744,200nM,24,myeloblast,blood,Acute myeloblastic leukemia,other
PRJNA603369,mv411.abbv744.200nM,MV-4-11,ABBV-744,200nM,24,lymphoblast,blood,Biphenotypic B Myelomonocytic Leukemia,other
PRJNA603369,nci_h1299.abbv744.200nM,NCI-H1299,ABBV-744,200nM,24,epithelial,lung,Carcinoma,other
PRJNA603369,skm.abbv744.200nM,SKM-1,ABBV-744,200nM,24,myeloblast,blood,Acute myeloid leukemia,other
PRJNA379584,afatinib.24,H-STS NET,afatinib,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,afatinib.6,H-STS NET,afatinib,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,alisertib.24,H-STS NET,alisertib,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,alisertib.6,H-STS NET,alisertib,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,arachidonyl.24,H-STS NET,arachidonyl,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,arachidonyl.6,H-STS NET,arachidonyl,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,at13387.24,H-STS NET,at13387,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,at13387.6,H-STS NET,at13387,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,auy922.24,H-STS NET,auy922,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,auy922.6,H-STS NET,auy922,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA670901,HH.azacitidine,HH,Azacitidine,50/125/250nM,NA,lymphoblast,blood,Lymphoma,other
PRJNA670901,HH.azacitidine_125nM,HH,Azacitidine,125nM,NA,lymphoblast,blood,Lymphoma,other
PRJNA670901,HH.azacitidine_250nM,HH,Azacitidine,250nM,NA,lymphoblast,blood,Lymphoma,other
PRJNA670901,HH.azacitidine_50nM,HH,Azacitidine,50nM,NA,lymphoblast,blood,Lymphoma,other
PRJNA670901,PF382.azacitidine,PF-382,Azacitidine,50/125/250nM,NA,lymphoblast,blood,Acute lymphoblastic leukemia ALL,other
PRJNA670901,PF382.azacitidine_125nM,PF-382,Azacitidine,125nM,NA,lymphoblast,blood,Acute lymphoblastic leukemia ALL,other
PRJNA670901,PF382.azacitidine_250nM,PF-382,Azacitidine,250nM,NA,lymphoblast,blood,Acute lymphoblastic leukemia ALL,other
PRJNA670901,PF382.azacitidine_500nM,PF-382,Azacitidine,500nM,NA,lymphoblast,blood,Acute lymphoblastic leukemia ALL,other
PRJNA670901,azacitidine_125nM,TCL,Azacitidine,125nM,NA,lymphoblast,blood,Acute lymphoblastic leukemia ALL,other
PRJNA670901,azacitidine_250nM,TCL,Azacitidine,250nM,NA,lymphoblast,blood,Acute lymphoblastic leukemia ALL,other
PRJNA670901,azacitidine_50nM,TCL,Azacitidine,50nM,NA,lymphoblast,blood,Acute lymphoblastic leukemia ALL,other
PRJNA670901,TLOm1.azacitidine,TLOm1,Azacitidine,50/125/250nM,NA,lymphoblast,blood,Acute lymphoblastic leukemia ALL,other
PRJNA670901,TLOm1.azacitidine_125nM,TLOm1,Azacitidine,125nM,NA,lymphoblast,blood,Acute lymphoblastic leukemia ALL,other
PRJNA670901,TLOm1.azacitidine_250nM,TLOm1,Azacitidine,250nM,NA,lymphoblast,blood,Acute lymphoblastic leukemia ALL,other
PRJNA670901,TLOm1.azacitidine_500nM,TLOm1,Azacitidine,500nM,NA,lymphoblast,blood,Acute lymphoblastic leukemia ALL,other
PRJNA379584,azd6482.24,H-STS NET,azd6482,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,azd6482.6,H-STS NET,azd6482,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,azd7762.24,H-STS NET,azd7762,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,azd7762.6,H-STS NET,azd7762,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,azd8055.24,H-STS NET,azd8055,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,azd8055.6,H-STS NET,azd8055,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,bafetinib.24,H-STS NET,bafetinib,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,bafetinib.6,H-STS NET,bafetinib,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,bardoxolone_methyl.24,H-STS NET,bardoxolone_methyl,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,bardoxolone_methyl.6,H-STS NET,bardoxolone_methyl,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,belinostat.24,H-STS NET,belinostat,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,belinostat.6,H-STS NET,belinostat,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,bexarotene.24,H-STS NET,bexarotene,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,bexarotene.6,H-STS NET,bexarotene,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,bgj398.24,H-STS NET,bgj398,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,bgj398.6,H-STS NET,bgj398,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,bi.6,H-STS NET,bi,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,bi_2536.24,H-STS NET,bi_2536,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,bi_2536.6,H-STS NET,bi_2536,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,bio.24,H-STS NET,bio,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,bio.6,H-STS NET,bio,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,bkm120.24,H-STS NET,bkm120,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,bkm120.6,H-STS NET,bkm120,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,bms.6,H-STS NET,bms,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,bms_754807.24,H-STS NET,bms_754807,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,bms_754807.6,H-STS NET,bms_754807,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,bortezomib.24,H-STS NET,bortezomib,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,bortezomib.6,H-STS NET,bortezomib,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,brefeldin_a.24,H-STS NET,brefeldin_a,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,brefeldin_a.6,H-STS NET,brefeldin_a,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,brivanib.24,H-STS NET,brivanib,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,brivanib.6,H-STS NET,brivanib,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA533647,PCIA_Bu,HFSC,Busulfan,20mg/kg/day,,primary human cells,scalp,Normal,other
PRJNA533647,PCIA_BuCy,HFSC,Busulfan + Cyclophosphamide,20mg/kg/day + 100mg/kg/day,,primary human cells,scalp,Normal,other
PRJNA379584,byl719.24,H-STS NET,byl719,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,byl719.6,H-STS NET,byl719,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA392914,carboplatin.50uM_72hr,PC9,Carboplatin,50uM,72,epithelial,lung,Carcinoma,other
PRJNA379584,cay10618_in_methanol.24,H-STS NET,cay10618_in_methanol,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,cay10618_in_methanol.6,H-STS NET,cay10618_in_methanol,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,cd.6,H-STS NET,cd,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,cd_437.24,H-STS NET,cd_437,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,cd_437.6,H-STS NET,cd_437,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,cerulenin.24,H-STS NET,cerulenin,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,cerulenin.6,H-STS NET,cerulenin,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,chm.24,H-STS NET,chm,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,chm_1.24,H-STS NET,chm_1,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,chm_1.6,H-STS NET,chm_1,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,ciclopirox.24,H-STS NET,ciclopirox,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,ciclopirox.6,H-STS NET,ciclopirox,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA685849,CDDP_50uM_10hr,A375p,Cisplatin,NA,10,epithelial,skin,Malignant Melanoma,other
PRJNA685849,CDDP_50uM_20hr,A375p,Cisplatin,NA,20,epithelial,skin,Malignant Melanoma,other
PRJNA685849,CDDP_50uM_4hr,A375p,Cisplatin,NA,4,epithelial,skin,Malignant Melanoma,other
PRJNA657067,Cotyledon_orbiculata_extract,HCT116,Cotyledon_orbiculata_extract,Cotyledon orbiculata extract,,epithelial,large intestine; colon,Carcinoma,other
PRJNA379584,crizotinib.24,H-STS NET,crizotinib,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,crizotinib.6,H-STS NET,crizotinib,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,d_be_q.24,H-STS NET,d_be_q,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,d_be_q.6,H-STS NET,d_be_q,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,dasatinib.24,H-STS NET,dasatinib,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,dasatinib.6,H-STS NET,dasatinib,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA596778,dac_100nM.786,786-0,Decitabine,100nM,120,epithelial,kidney,Adenocarcinoma,Decitabine
PRJNA596778,dac_300nM.786,786-0,Decitabine,300nM,120,epithelial,kidney,Adenocarcinoma,Decitabine
PRJNA596778,dac,786-0,Decitabine,300/100nM,120,epithelial,kidney,Adenocarcinoma,Decitabine
PRJNA596778,dac.100nM,786-0,Decitabine,100nM,120,epithelial,kidney,Adenocarcinoma,Decitabine
PRJNA596778,dac.300nM,786-0,Decitabine,300nM,120,epithelial,kidney,Adenocarcinoma,Decitabine
PRJNA260377,cmml1_resonder,BM MNC,Decitabine,20 mg/m2/day i.v.,3 cycles 5d/28d,primary human cells,bone,chronic myelomonocytic leukemia ,Decitabine
PRJNA260377,cmml2_respnder,BM MNC,Decitabine,20 mg/m2/day i.v.,3 cycles 5d/28d,primary human cells,bone,chronic myelomonocytic leukemia ,Decitabine
PRJNA260377,responder,BM MNC,Decitabine,20 mg/m2/day i.v.,3 cycles 5d/28d,primary human cells,bone,chronic myelomonocytic leukemia ,Decitabine
PRJNA657045,Till_CAR.dac_14d_vs_7d,CAR T,Decitabine,NA,336,PBMC,blood,,Decitabine
PRJNA657045,Till_dCAR.dac_14d_vs_7d,CAR T,Decitabine,NA,336,PBMC,blood,,Decitabine
PRJNA318019,dac,GBM,Decitabine,1uM,72,epithelial,brain,Glioblastoma,Decitabine
PRJNA642730,dac,GSC,Decitabine,NA,NA,epithelial,brain,Glioblastoma,Decitabine
PRJNA670901,HH.dac,HH,Decitabine,5/12.5/25nM,NA,lymphoblast,blood,Lymphoma,Decitabine
PRJNA670901,HH.dac_12.5nM,HH,Decitabine,12.5nM,NA,lymphoblast,blood,Lymphoma,Decitabine
PRJNA670901,HH.dac_25nM,HH,Decitabine,25nM,NA,lymphoblast,blood,Lymphoma,Decitabine
PRJNA670901,HH.dac_5nM,HH,Decitabine,5nM,NA,lymphoblast,blood,Lymphoma,Decitabine
PRJNA596778,HKC.dac_100nM,HKC,Decitabine,100nM,120,epithelial,kidney,Adenocarcinoma,Decitabine
PRJNA596778,HKC.dac_300nM,HKC,Decitabine,300nM,120,epithelial,kidney,Adenocarcinoma,Decitabine
PRJNA316529,dac,HL-60,Decitabine,100nM,72,promyeloblast,blood,acute promyelocytic leukemia,Decitabine
PRJNA318019,lnt_dac,LNT-299,Decitabine,1uM,72,epithelial,brain,Glioblastoma,Decitabine
PRJNA649432,Loucy.dac,Loucy,Decitabine,NA,NA,lymphoblast,blood,Acute lymphoblastic leukemia ALL,Decitabine
PRJNA607909,dac,LUAD,Decitabine,100nM,72,,lung,,Decitabine
PRJNA649432,MOLT_16.dac,MOLT,Decitabine,NA,NA,lymphoblast,blood,Acute lymphoblastic leukemia ALL,Decitabine
PRJNA642730,NCH1681.dac,NCH1681,Decitabine,NA,NA,epithelial,brain,Glioblastoma,Decitabine
PRJNA642730,NCH612.dac,NCH612,Decitabine,NA,NA,epithelial,brain,Glioblastoma,Decitabine
PRJNA649432,PEER.dac,PEER,Decitabine,NA,NA,lymphoblast,blood,Acute lymphoblastic leukemia ALL,Decitabine
PRJNA649432,PER_117.dac,PER,Decitabine,NA,NA,lymphoblast,blood,Acute lymphoblastic leukemia ALL,Decitabine
PRJNA670901,PF382.dac,PF-382,Decitabine,5/12.5/25nM,NA,lymphoblast,blood,Acute lymphoblastic leukemia ALL,Decitabine
PRJNA670901,PF382.dac_12.5nM,PF-382,Decitabine,12.5nM,NA,lymphoblast,blood,Acute lymphoblastic leukemia ALL,Decitabine
PRJNA670901,PF382.dac_25nM,PF-382,Decitabine,25nM,NA,lymphoblast,blood,Acute lymphoblastic leukemia ALL,Decitabine
PRJNA670901,PF382.dac_5nM,PF-382,Decitabine,5nM,NA,lymphoblast,blood,Acute lymphoblastic leukemia ALL,Decitabine
PRJNA642730,SU_AO3.dac,SU-AO3,Decitabine,NA,NA,epithelial,brain,Glioblastoma,Decitabine
PRJNA265187,dac,SW48,Decitabine,NA,NA,epithelial,large intestine; colon,"Adenocarcinoma; Colorectal; Dukes' type C, grade IV",Decitabine
PRJNA649431,dac,T-ALL,Decitabine,NA,NA,lymphoblast,blood,Acute lymphoblastic leukemia ALL,Decitabine
PRJNA649432,dac,T-ALL,Decitabine,NA,NA,lymphoblast,blood,Acute lymphoblastic leukemia ALL,Decitabine
PRJNA649431,PDX_TALL1.dac,T-ALL1,Decitabine,NA,NA,lymphoblast,blood,Acute lymphoblastic leukemia ALL,Decitabine
PRJNA649432,TALL_1.dac,T-ALL1,Decitabine,NA,NA,lymphoblast,blood,Acute lymphoblastic leukemia ALL,Decitabine
PRJNA649431,PDX_TALL2.dac,T-ALL2,Decitabine,NA,NA,lymphoblast,blood,Acute lymphoblastic leukemia ALL,Decitabine
PRJNA318019,t98g_dac,T98G,Decitabine,1uM,72,epithelial,brain,Glioblastoma,Decitabine
PRJNA670901,dac_12.5nM,TCL,Decitabine,12.5nM,NA,lymphoblast,blood,Acute lymphoblastic leukemia ALL,Decitabine
PRJNA670901,dac_25nM,TCL,Decitabine,25nM,NA,lymphoblast,blood,Acute lymphoblastic leukemia ALL,Decitabine
PRJNA670901,dac_5nM,TCL,Decitabine,5nM,NA,lymphoblast,blood,Acute lymphoblastic leukemia ALL,Decitabine
PRJNA670901,TLOm1.dac,TLOm1,Decitabine,5/12.5/25nM,NA,lymphoblast,blood,Acute lymphoblastic leukemia ALL,Decitabine
PRJNA670901,TLOm1.dac_12.5nM,TLOm1,Decitabine,12.5nM,NA,lymphoblast,blood,Acute lymphoblastic leukemia ALL,Decitabine
PRJNA670901,TLOm1.dac_25nM,TLOm1,Decitabine,25nM,NA,lymphoblast,blood,Acute lymphoblastic leukemia ALL,Decitabine
PRJNA670901,TLOm1.dac_5nM,TLOm1,Decitabine,5nM,NA,lymphoblast,blood,Acute lymphoblastic leukemia ALL,Decitabine
PRJNA642730,TS603.dac,TS603,Decitabine,NA,NA,epithelial,brain,Glioblastoma,Decitabine
PRJNA318019,u87_dac,U-87,Decitabine,1uM,72,epithelial,brain,Glioblastoma,Decitabine
hh1,dac_96hr,YB5,Decitabine,NA,96,epithelial,large intestine; colon,"Adenocarcinoma; Colorectal; Dukes' type C, grade IV",Decitabine
proa,dac,YB5,Decitabine,100nM,48,epithelial,large intestine; colon,"Adenocarcinoma; Colorectal; Dukes' type C, grade IV",Decitabine
tak,dac,YB5,Decitabine,100nM,96,epithelial,large intestine; colon,"Adenocarcinoma; Colorectal; Dukes' type C, grade IV",Decitabine
PRJNA316529,dac_deazaneplanocinA,HL-60,Decitabine + 3-deazaneplanocin A,100nM + 1000nM,72,promyeloblast,blood,acute promyelocytic leukemia,other
tak,dac_depsi,YB5,Decitabine + Depsipeptide,100nM + 20nM,96,epithelial,large intestine; colon,"Adenocarcinoma; Colorectal; Dukes' type C, grade IV",other
tak,dac_gsk343,YB5,Decitabine + GSK343,100nM + 1uM,96,epithelial,large intestine; colon,"Adenocarcinoma; Colorectal; Dukes' type C, grade IV",other
hh1,dac_hh1_10um_96hr,YB5,Decitabine + HH1,10uM,96,epithelial,large intestine; colon,"Adenocarcinoma; Colorectal; Dukes' type C, grade IV",other
hh1,dac_hh1_25um_96hr,YB5,Decitabine + HH1,25uM,96,epithelial,large intestine; colon,"Adenocarcinoma; Colorectal; Dukes' type C, grade IV",other
proa,dac_proa,YB5,Decitabine + Proscillaridin A,100nM + 50nM,48,epithelial,large intestine; colon,"Adenocarcinoma; Colorectal; Dukes' type C, grade IV",other
PRJNA657045,dCAR.dac_Raij_vs_dac,CAR,Decitabine + Raij coculture,NA,336,PBMC,blood,,other
tak,dac_s2102,YB5,Decitabine + S2101,100nM + 10uM,96,epithelial,large intestine; colon,"Adenocarcinoma; Colorectal; Dukes' type C, grade IV",other
PRJNA265187,dac_siCHD4,SW48,Decitabine + siCHD4,NA,NA,epithelial,large intestine; colon,"Adenocarcinoma; Colorectal; Dukes' type C, grade IV",other
tak,dac_unc0628,YB5,Decitabine + UNC0638,100nM + 1uM,96,epithelial,large intestine; colon,"Adenocarcinoma; Colorectal; Dukes' type C, grade IV",other
tak,depsi,YB5,Depsipeptide,20nM,96,epithelial,large intestine; colon,"Adenocarcinoma; Colorectal; Dukes' type C, grade IV",Depsipeptide
PRJNA379584,dinaciclib.24,H-STS NET,dinaciclib,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,dinaciclib.6,H-STS NET,dinaciclib,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,dmso.24,H-STS NET,dmso,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,dmso.6,H-STS NET,dmso,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,docetaxel.24,H-STS NET,docetaxel,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,docetaxel.6,H-STS NET,docetaxel,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA335388,doxorubicin.1uM,Breast/Osteosarcoma,Doxorubicin,1uM,72,epithelial,breast + bone,,Doxorubicin
PRJNA315294,doxorubicin.300nM.16h,CRC,Doxorubicin,300nM,16,epithelial,large intestine; colon,"Adenocarcinoma; Colorectal; Dukes' type C, grade IV",Doxorubicin
PRJNA379584,doxorubicin.24,H-STS NET,Doxorubicin,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,Doxorubicin
PRJNA379584,doxorubicin.6,H-STS NET,Doxorubicin,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,Doxorubicin
PRJNA315294,hct_dox,HCT116,Doxorubicin,300nM,16,epithelial,large intestine; colon,Carcinoma,Doxorubicin
PRJNA315294,hct_ko_dox,HCT116_p53_KO,Doxorubicin,300nM,16,epithelial,large intestine; colon,Carcinoma,Doxorubicin
PRJNA315294,hct_wt_dox,HCT116_p53_WT,Doxorubicin,300nM,16,epithelial,large intestine; colon,Carcinoma,Doxorubicin
PRJNA555350,doxorubicin,HEL,Doxorubicin,3mg/kg,120,lymphoblast,bone,Erythroleukemia,Doxorubicin
PRJNA335388,bc_dox,MDA-MB231,Doxorubicin,1uM,72,epithelial,breast,Adenocarcinoma,Doxorubicin
PRJNA315294,rko_dox,RKO,Doxorubicin,300nM,16,epithelial,large intestine; colon,Carcinoma,Doxorubicin
PRJNA315294,rko_ko_dox,RKO_p53_KO,Doxorubicin,300nM,16,epithelial,large intestine; colon,Carcinoma,Doxorubicin
PRJNA315294,rko_wt_dox,RKO_p53_WT,Doxorubicin,300nM,16,epithelial,large intestine; colon,Carcinoma,Doxorubicin
PRJNA315294,sw48_dox,SW48,Doxorubicin,300nM,16,epithelial,large intestine; colon,"Adenocarcinoma; Colorectal; Dukes' type C, grade IV",Doxorubicin
PRJNA315294,sw48_ko_dox,SW48_p53_KO,Doxorubicin,300nM,16,epithelial,large intestine; colon,"Adenocarcinoma; Colorectal; Dukes' type C, grade IV",Doxorubicin
PRJNA315294,sw48_wt_dox,SW48_p53_WT,Doxorubicin,300nM,16,epithelial,large intestine; colon,"Adenocarcinoma; Colorectal; Dukes' type C, grade IV",Doxorubicin
PRJNA335388,os_dox,U2OS,Doxorubicin,1uM,72,epithelial,bone,Osteosarcoma,Doxorubicin
PRJNA555350,doxorubicin_cytabine,HEL,Doxorubicin + Cytarabine,3mg/kg + 100mg/kg,120,lymphoblast,bone,Erythroleukemia,other
PRJNA555350,doxorubicin_cytabine_decitabine,HEL,Doxorubicin + Cytarabine + Decitibine,3mg/kg + 100mg/kg + 0.5mg/kg,120,lymphoblast,bone,Erythroleukemia,other
PRJNA379584,entinostat.24,H-STS NET,entinostat,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,entinostat.6,H-STS NET,entinostat,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,epigallocatechin_gallate.24,H-STS NET,epigallocatechin_gallate,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,epigallocatechin_gallate.6,H-STS NET,epigallocatechin_gallate,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,erastin.24,H-STS NET,erastin,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,erastin.6,H-STS NET,erastin,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA392914,erlotinib.1uM_24hr,PC9,Erlotinib,1um,24,epithelial,lung,Carcinoma,other
PRJNA379584,ethanol.24,H-STS NET,ethanol,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,ethanol.6,H-STS NET,ethanol,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA335388,etoposide.20uM,Breast/Osteosarcoma,Etoposide,20uM,72,epithelial,breast + bone,,Etoposide
PRJNA387040,etoposide,IMR90,Etoposide,100uM,48,fibroblast,lung,Normal,Etoposide
PRJNA387040,wt_eto,IMR90_shCGAS,Etoposide,100uM,48,fibroblast,lung,Normal,Etoposide
PRJNA387040,ko_eto,IMR90_shNTC,Etoposide,100uM,48,fibroblast,lung,Normal,Etoposide
PRJNA335388,bc_eto,MDA-MB231,Etoposide,20uM,72,epithelial,breast,Adenocarcinoma,Etoposide
PRJNA335388,os_eto,U2OS,Etoposide,20uM,72,epithelial,bone,Osteosarcoma,Etoposide
PRJNA379584,fingolimod.24,H-STS NET,fingolimod,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,fingolimod.6,H-STS NET,fingolimod,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,fk866.24,H-STS NET,fk866,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,fk866.6,H-STS NET,fk866,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,flavopiridol.24,H-STS NET,flavopiridol,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,flavopiridol.6,H-STS NET,flavopiridol,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,fluvastatin.24,H-STS NET,fluvastatin,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,fluvastatin.6,H-STS NET,fluvastatin,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,foretinib.24,H-STS NET,foretinib,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,foretinib.6,H-STS NET,foretinib,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,gdc.6,H-STS NET,gdc,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,gdc_0941.24,H-STS NET,gdc_0941,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,gdc_0941.6,H-STS NET,gdc_0941,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,gemcitabine.24,H-STS NET,gemcitabine,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,gemcitabine.6,H-STS NET,gemcitabine,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,gossypol.24,H-STS NET,gossypol,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,gossypol.6,H-STS NET,gossypol,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,gsk1210151a.24,H-STS NET,gsk1210151a,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,gsk1210151a.6,H-STS NET,gsk1210151a,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
tak,gsk343,YB5,GSK343,1uM,96,epithelial,large intestine; colon,"Adenocarcinoma; Colorectal; Dukes' type C, grade IV",GSK343
PRJNA379584,gsk461364.24,H-STS NET,gsk461364,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,gsk461364.6,H-STS NET,gsk461364,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,gw.6,H-STS NET,gw,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,gw_405833.24,H-STS NET,gw_405833,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,gw_405833.6,H-STS NET,gw_405833,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
hh1,hh1_24hr,YB5,HH1,10uM,24,epithelial,large intestine; colon,"Adenocarcinoma; Colorectal; Dukes' type C, grade IV",HH1
hh1,hh1_25um_96hr,YB5,HH1,25uM,96,epithelial,large intestine; colon,"Adenocarcinoma; Colorectal; Dukes' type C, grade IV",HH1
hh1,hh1_2hr,YB5,HH1,10uM,2,epithelial,large intestine; colon,"Adenocarcinoma; Colorectal; Dukes' type C, grade IV",HH1
hh1,hh1_4hr,YB5,HH1,10uM,4,epithelial,large intestine; colon,"Adenocarcinoma; Colorectal; Dukes' type C, grade IV",HH1
hh1,hh1_8hr,YB5,HH1,10uM,8,epithelial,large intestine; colon,"Adenocarcinoma; Colorectal; Dukes' type C, grade IV",HH1
hh1,hh1_96hr,YB5,HH1,10uM,96,epithelial,large intestine; colon,"Adenocarcinoma; Colorectal; Dukes' type C, grade IV",HH1
PRJNA379584,hmn.6,H-STS NET,hmn,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,hmn_214.24,H-STS NET,hmn_214,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,hmn_214.6,H-STS NET,hmn_214,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA685849,Hypercin_150nM_irradiation_10hr,A375p,Hyp-PDT,NA,10,epithelial,skin,Malignant Melanoma,other
PRJNA685849,Hypercin_150nM_irradiation_20hr,A375p,Hyp-PDT,NA,20,epithelial,skin,Malignant Melanoma,other
PRJNA685849,Hypercin_150nM_irradiation_4hr,A375p,Hyp-PDT,NA,4,epithelial,skin,Malignant Melanoma,other
PRJNA379584,ibrutinib.24,H-STS NET,ibrutinib,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,ibrutinib.6,H-STS NET,ibrutinib,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,imatinib.24,H-STS NET,imatinib,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,imatinib.6,H-STS NET,imatinib,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,inc280.24,H-STS NET,inc280,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,inc280.6,H-STS NET,inc280,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,istradefylline.24,H-STS NET,istradefylline,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,istradefylline.6,H-STS NET,istradefylline,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,jnj.6,H-STS NET,jnj,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,jnj_26854165.24,H-STS NET,jnj_26854165,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,jnj_26854165.6,H-STS NET,jnj_26854165,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,khs101.24,H-STS NET,khs101,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,khs101.6,H-STS NET,khs101,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,ku.6,H-STS NET,ku,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,ku_0063794.24,H-STS NET,ku_0063794,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,ku_0063794.6,H-STS NET,ku_0063794,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,kw.6,H-STS NET,kw,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,kw_2449.24,H-STS NET,kw_2449,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,kw_2449.6,H-STS NET,kw_2449,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,kx2.24,H-STS NET,kx2,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,kx2_391.24,H-STS NET,kx2_391,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,kx2_391.6,H-STS NET,kx2_391,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,ldk378.24,H-STS NET,ldk378,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,ldk378.6,H-STS NET,ldk378,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,lee011.24,H-STS NET,lee011,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,lee011.6,H-STS NET,lee011,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,leptomycin_b_in_ethanol.24,H-STS NET,leptomycin_b_in_ethanol,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,leptomycin_b_in_ethanol.6,H-STS NET,leptomycin_b_in_ethanol,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,linifanib.24,H-STS NET,linifanib,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,linifanib.6,H-STS NET,linifanib,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,ly.6,H-STS NET,ly,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,ly_2183240.24,H-STS NET,ly_2183240,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,ly_2183240.6,H-STS NET,ly_2183240,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,manumycin_a.24,H-STS NET,manumycin_a,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,manumycin_a.6,H-STS NET,manumycin_a,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,methanol.24,H-STS NET,methanol,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,methanol.6,H-STS NET,methanol,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,methylstat.24,H-STS NET,methylstat,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,methylstat.6,H-STS NET,methylstat,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,mg.6,H-STS NET,mg,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,mg_132.24,H-STS NET,mg_132,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,mg_132.6,H-STS NET,mg_132,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,mithramycin_a.24,H-STS NET,mithramycin_a,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,mithramycin_a.6,H-STS NET,mithramycin_a,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA636096,MCC.5637,5637,Mitomycin C,30uM,48,epithelial,bladder,Bladder Carcinoma,Mitomycin C
PRJNA636096,MCC,BLCA,Mitomycin C,30uM,48,epithelial,bladder,Bladder Carcinoma,Mitomycin C
PRJNA636096,MCC.CLS_439,CLS-439,Mitomycin C,30uM,48,epithelial,bladder,Bladder Carcinoma,Mitomycin C
PRJNA636096,MCC.T24,T24,Mitomycin C,30uM,48,epithelial,bladder,Transitional cell carcinoma,Mitomycin C
PRJNA636096,MCC.TCC_SUP,TCC-SUP,Mitomycin C,30uM,48,epithelial,bladder,Carcinoma,Mitomycin C
PRJNA379584,mitomycin_c.24,H-STS NET,Mitomycin C,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,Mitomycin C
PRJNA379584,mitomycin_c.6,H-STS NET,Mitomycin C,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,Mitomycin C
PRJNA685849,MTX_1um_10hr,A375p,Mitoxantrone,NA,10,epithelial,skin,Malignant Melanoma,other
PRJNA685849,MTX_1um_20hr,A375p,Mitoxantrone,NA,20,epithelial,skin,Malignant Melanoma,other
PRJNA685849,MTX_1um_4hr,A375p,Mitoxantrone,NA,4,epithelial,skin,Malignant Melanoma,other
PRJNA379584,mk.24,H-STS NET,mk,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,mk.6,H-STS NET,mk,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,mk_1775.24,H-STS NET,mk_1775,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,mk_1775.6,H-STS NET,mk_1775,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,mk_2206.24,H-STS NET,mk_2206,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,mk_2206.6,H-STS NET,mk_2206,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,ml210.24,H-STS NET,ml210,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,ml210.6,H-STS NET,ml210,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA335388,mms.40ug_ml,Breast/Osteosarcoma,MMS,40 ug/mL,72,epithelial,breast + bone,,other
PRJNA335388,bc_mms,MDA-MB231,MMS,40 ug/mL,72,epithelial,breast,Adenocarcinoma,other
PRJNA335388,os_mms,U2OS,MMS,40 ug/mL,72,epithelial,bone,Osteosarcoma,other
PRJNA379584,mst.6,H-STS NET,mst,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,mst_312.24,H-STS NET,mst_312,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,mst_312.6,H-STS NET,mst_312,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,n_ilotinib.24,H-STS NET,n_ilotinib,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,n_ilotinib.6,H-STS NET,n_ilotinib,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA471642,mec1_vs_gm12878,MEC1,NA,NA,NA,lymphoblast,blood,Chronic lymphocytic leukemia,other
PRJNA497893,hpv16,NOK,NA,NA,NA,epithelial,skin,Carcinoma,other
PRJNA497893,hpv16_e2,NOK,NA,NA,NA,epithelial,skin,Carcinoma,other
PRJNA392914,dtp,PC9,NA,NA,NA,epithelial,lung,Carcinoma,other
PRJNA379584,necrosulfonamide.24,H-STS NET,necrosulfonamide,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,necrosulfonamide.6,H-STS NET,necrosulfonamide,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,neratinib.24,H-STS NET,neratinib,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,neratinib.6,H-STS NET,neratinib,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,nutlin.6,H-STS NET,nutlin,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,nutlin_3.24,H-STS NET,nutlin_3,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,nutlin_3.6,H-STS NET,nutlin_3,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA391270,a549_nut,A459,Nutlin3A,5uM,NA,epithelial,lung,Carcinoma,other
PRJNA391270,a549_tgfb_nut,A459,Nutlin3A + TGFB,5uM + 2.5ng/ml,120,epithelial,lung,Carcinoma,other
PRJNA379584,nvp.6,H-STS NET,nvp,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,nvp_231.24,H-STS NET,nvp_231,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,nvp_231.6,H-STS NET,nvp_231,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,obatoclax.24,H-STS NET,obatoclax,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,obatoclax.6,H-STS NET,obatoclax,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,pac.24,H-STS NET,pac,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,pac_1.24,H-STS NET,pac_1,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,pac_1.6,H-STS NET,pac_1,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA335388,paclitaxel.02uM,Breast/Osteosarcoma,Paclitaxel,0.2uM,72,epithelial,breast + bone,,Paclitaxel
PRJNA379584,paclitaxel.24,H-STS NET,Paclitaxel,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,Paclitaxel
PRJNA379584,paclitaxel.6,H-STS NET,Paclitaxel,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,Paclitaxel
PRJNA335388,bc_pac,MDA-MB231,Paclitaxel,0.2uM,72,epithelial,breast,Adenocarcinoma,Paclitaxel
PRJNA335388,os_pac,U2OS,Paclitaxel,0.2uM,72,epithelial,bone,Osteosarcoma,Paclitaxel
PRJNA379584,panobinostat.24,H-STS NET,panobinostat,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,panobinostat.6,H-STS NET,panobinostat,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,parbendazole.24,H-STS NET,parbendazole,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,parbendazole.6,H-STS NET,parbendazole,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,parthenolide.24,H-STS NET,parthenolide,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,parthenolide.6,H-STS NET,parthenolide,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,pf.6,H-STS NET,pf,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,pf_3758309.24,H-STS NET,pf_3758309,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,pf_3758309.6,H-STS NET,pf_3758309,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,pf_573228.24,H-STS NET,pf_573228,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,pf_573228.6,H-STS NET,pf_573228,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,pha.6,H-STS NET,pha,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,pha_665752.24,H-STS NET,pha_665752,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,pha_665752.6,H-STS NET,pha_665752,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,piperlongumine.24,H-STS NET,piperlongumine,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,piperlongumine.6,H-STS NET,piperlongumine,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,pkc412.24,H-STS NET,pkc412,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,pkc412.6,H-STS NET,pkc412,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
pladb,pladb_10nM,YB5,Pladienolide B,10nM,72,epithelial,large intestine; colon,"Adenocarcinoma; Colorectal; Dukes' type C, grade IV",Pladienolide B
pladb,pladb_150nM,YB5,Pladienolide B,150nM,72,epithelial,large intestine; colon,"Adenocarcinoma; Colorectal; Dukes' type C, grade IV",Pladienolide B
PRJNA379584,pluripotin.24,H-STS NET,pluripotin,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,pluripotin.6,H-STS NET,pluripotin,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
proa,proa,YB5,Proscillaridin A,50nM,48,epithelial,large intestine; colon,"Adenocarcinoma; Colorectal; Dukes' type C, grade IV",Proscillaridin A
PRJNA379584,rad001.24,H-STS NET,rad001,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,rad001.6,H-STS NET,rad001,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA657045,CAR.Raij,CAR,Raij coculture,NA,336,PBMC,blood,,other
PRJNA379584,rigosertib.24,H-STS NET,rigosertib,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,rigosertib.6,H-STS NET,rigosertib,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,rosiglitazone.24,H-STS NET,rosiglitazone,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,rosiglitazone.6,H-STS NET,rosiglitazone,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
tak,s2102,YB5,S2101,10uM,96,epithelial,large intestine; colon,"Adenocarcinoma; Colorectal; Dukes' type C, grade IV",S2101
PRJNA379584,sb.6,H-STS NET,sb,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,sb_225002.24,H-STS NET,sb_225002,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,sb_225002.6,H-STS NET,sb_225002,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,sb_743921.24,H-STS NET,sb_743921,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,sb_743921.6,H-STS NET,sb_743921,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA670855,sbi756.4hr,non-Hogkin lymphoma,SBI-756,NA,4,lymphoblast,lymph node,Large cell Lymphoma,other
PRJNA379584,sch.24,H-STS NET,sch,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,sch.6,H-STS NET,sch,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,sch_529074.24,H-STS NET,sch_529074,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,sch_529074.6,H-STS NET,sch_529074,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,sch_79797.24,H-STS NET,sch_79797,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,sch_79797.6,H-STS NET,sch_79797,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA471642,SD6.125nm.24hr,CLL,SD6,125nM,24,lymphoblast,blood,Chronic lymphocytic leukemia,other
PRJNA471642,SD6.125nm.2hr,CLL,SD6,125nM,2,lymphoblast,blood,Chronic lymphocytic leukemia,other
PRJNA471642,SD6.125nm.6hr,CLL,SD6,125nM,6,lymphoblast,blood,Chronic lymphocytic leukemia,other
PRJNA265187,siCHD4,SW48,siCHD4,NA,NA,epithelial,large intestine; colon,"Adenocarcinoma; Colorectal; Dukes' type C, grade IV",other
PRJNA265187,siDMNT1,SW48,siDMNT1,NA,NA,epithelial,large intestine; colon,"Adenocarcinoma; Colorectal; Dukes' type C, grade IV",other
PRJNA265187,siDNMT1_siCHD4,SW48,siDNMT1 + siCHD4,NA,NA,epithelial,large intestine; colon,"Adenocarcinoma; Colorectal; Dukes' type C, grade IV",other
PRJNA379584,snx.6,H-STS NET,snx,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,snx_2112.24,H-STS NET,snx_2112,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,snx_2112.6,H-STS NET,snx_2112,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,sorafenib.24,H-STS NET,sorafenib,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,sorafenib.6,H-STS NET,sorafenib,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,su11274.24,H-STS NET,su11274,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,su11274.6,H-STS NET,su11274,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,sunitinib.24,H-STS NET,sunitinib,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,sunitinib.6,H-STS NET,sunitinib,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA560975,tedizolid.5uM.4d,MOLM13,Tedizolid,5uM,96,lymphoblast,blood,Acute lymphoblastic leukemia ALL,other
hh1,tetOff,YB5,tetOff,NA,72,epithelial,large intestine; colon,"Adenocarcinoma; Colorectal; Dukes' type C, grade IV",tetOff
PRJNA391270,a549_tgfb,A459,TGFB,2.5ng/ml,120,epithelial,lung,Carcinoma,other
PRJNA477352,j4.thz1_250nM_6hr,HBL-2 MCL ABT-199 DTP,THZ1,250nM,6,epithelial,blood,Mantle cell lymphoma,THZ1
PRJNA477352,j4.thz1_50nM_6hr,HBL-2 MCL ABT-199 DTP,THZ1,50nM,6,epithelial,blood,Mantle cell lymphoma,THZ1
PRJNA477352,l10.thz1_250nM_6hr,HBL-2 MCL ABT-199 DTP,THZ1,250nM,6,epithelial,blood,Mantle cell lymphoma,THZ1
PRJNA477352,l10.thz1_50nM_6hr,HBL-2 MCL ABT-199 DTP,THZ1,50nM,6,epithelial,blood,Mantle cell lymphoma,THZ1
PRJNA477352,l20.thz1_250nM_6hr,HBL-2 MCL ABT-199 DTP,THZ1,250nM,6,epithelial,blood,Mantle cell lymphoma,THZ1
PRJNA477352,l20.thz1_50nM_6hr,HBL-2 MCL ABT-199 DTP,THZ1,50nM,6,epithelial,blood,Mantle cell lymphoma,THZ1
PRJNA477352,par.thz1_250nM_6hr,HBL-2 MCL ABT-199 DTP,THZ1,250nM,6,epithelial,blood,Mantle cell lymphoma,THZ1
PRJNA477352,par.thz1_50nM_6hr,HBL-2 MCL ABT-199 DTP,THZ1,50nM,6,epithelial,blood,Mantle cell lymphoma,THZ1
PRJNA477352,thz1_250nM_6hr,HBL-2 MCL ABT-199 DTP,THZ1,250nM,6,epithelial,blood,Mantle cell lymphoma,THZ1
PRJNA477352,thz1_50nM_6hr,HBL-2 MCL ABT-199 DTP,THZ1,50nM,6,epithelial,blood,Mantle cell lymphoma,THZ1
PRJNA379584,tivantinib.24,H-STS NET,tivantinib,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,tivantinib.6,H-STS NET,tivantinib,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,topotecan.24,H-STS NET,topotecan,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,topotecan.6,H-STS NET,topotecan,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
toyo,toyo_10hr,YB5,Toyocamycin,NA,10,epithelial,large intestine; colon,"Adenocarcinoma; Colorectal; Dukes' type C, grade IV",Toyocamycin
toyo,toyo_24hr,YB5,Toyocamycin,NA,24,epithelial,large intestine; colon,"Adenocarcinoma; Colorectal; Dukes' type C, grade IV",Toyocamycin
toyo,toyo_2hr,YB5,Toyocamycin,NA,2,epithelial,large intestine; colon,"Adenocarcinoma; Colorectal; Dukes' type C, grade IV",Toyocamycin
toyo,toyo_48hr,YB5,Toyocamycin,NA,48,epithelial,large intestine; colon,"Adenocarcinoma; Colorectal; Dukes' type C, grade IV",Toyocamycin
toyo,toyo_72hr,YB5,Toyocamycin,NA,72,epithelial,large intestine; colon,"Adenocarcinoma; Colorectal; Dukes' type C, grade IV",Toyocamycin
PRJNA614994,trc105_vs_igg,AML,TRC105,NA,NA,primary human cells,blood,Acute myeloid leukemia,other
PRJNA392914,tsa.50nM_5hr,PC9,TSA,50nM,5,epithelial,lung,Carcinoma,other
PRJNA392914,dtp_tsa,PC9 DTP,TSA,50nM,5,epithelial,lung,Carcinoma,other
PRJNA379584,tw.6,H-STS NET,tw,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,tw_37.24,H-STS NET,tw_37,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,tw_37.6,H-STS NET,tw_37,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
tak,unc0628,YB5,UNC0628,1uM,96,epithelial,large intestine; colon,"Adenocarcinoma; Colorectal; Dukes' type C, grade IV",UNC0628
PRJNA560975,venetoclax.500nM.4d,MOLM13,Venetoclax,500nM,96,lymphoblast,blood,Acute lymphoblastic leukemia ALL,Venetoclax
PRJNA479415,venetoclax_azacitidine_6hr,AML,Venetoclax + Azacitidine,500nM + 2.5uM,6,primary human cells,blood,Acute myeloid leukemia,Venetoclax + Azacitidine
PRJNA560975,venetoclax.500nM_tedizolid.5uM.4d,MOLM13,Venetoclax + Tedizolid,500nM + 5uM,96,lymphoblast,blood,Acute lymphoblastic leukemia ALL,Venetoclax + Tedizolid
PRJNA379584,vincristine.24,H-STS NET,vincristine,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,vincristine.6,H-STS NET,vincristine,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,vorinostat.24,H-STS NET,vorinostat,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,vorinostat.6,H-STS NET,vorinostat,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,x5z_7_oxozeanol.24,H-STS NET,x5z_7_oxozeanol,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,x5z_7_oxozeanol.6,H-STS NET,x5z_7_oxozeanol,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,y.6,H-STS NET,y,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,y_27632.24,H-STS NET,y_27632,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,y_27632.6,H-STS NET,y_27632,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,yk_4.6,H-STS NET,yk_4,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,yk_4_279.24,H-STS NET,yk_4_279,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,yk_4_279.6,H-STS NET,yk_4_279,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,ym.6,H-STS NET,ym,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,ym_155.24,H-STS NET,ym_155,ED20 and 1/10 of it,24,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA379584,ym_155.6,H-STS NET,ym_155,ED20 and 1/10 of it,6,EBV-transformed lymphoblastoid cell line,pancreas; small bowel; rectum,Gastroenteropancreatic neuroendocrine tumors,other
PRJNA422779,G12V.MS275.1,CaCO-2et KRAS G12V,MS-275,NA,1,epithelial,large intestine; colon,Adenocarcinoma,other
PRJNA422779,G12V.MS275.6,CaCO-2et KRAS G12V,MS-275,NA,6,epithelial,large intestine; colon,Adenocarcinoma,other
PRJNA422779,G12V.MS275.24,CaCO-2et KRAS G12V,MS-275,NA,24,epithelial,large intestine; colon,Adenocarcinoma,other
PRJNA422779,G12V.MS275.72,CaCO-2et KRAS G12V,MS-275,NA,72,epithelial,large intestine; colon,Adenocarcinoma,other
PRJNA422779,WT.MS275.1,CaCO-2et KRAS WT,MS-275,NA,1,epithelial,large intestine; colon,Adenocarcinoma,other
PRJNA422779,WT.MS275.6,CaCO-2et KRAS WT,MS-275,NA,6,epithelial,large intestine; colon,Adenocarcinoma,other
PRJNA422779,WT.MS275.24,CaCO-2et KRAS WT,MS-275,NA,24,epithelial,large intestine; colon,Adenocarcinoma,other
PRJNA422779,WT.MS275.72,CaCO-2et KRAS WT,MS-275,NA,72,epithelial,large intestine; colon,Adenocarcinoma,other
PRJNA641077,iCRT3,HCT116,iCRT3,20nM,48,epithelial,large intestine; colon,Carcinoma,other
PRJNA641077,siCTNNB1,HCT116,siCTNNB1,20nM,48,epithelial,large intestine; colon,Carcinoma,other
PRJNA641077,siNeg,HCT116,siNeg,20nM,48,epithelial,large intestine; colon,Carcinoma,other
PRJNA641077,x1874,HCT116,GB1874,50uM,24,epithelial,large intestine; colon,Carcinoma,other
PRJNA641077,x6853,HCT116,GB6853,50uM,24,epithelial,large intestine; colon,Carcinoma,other
PRJNA641077,x8679,HCT116,GB8679,50uM,24,epithelial,large intestine; colon,Carcinoma,other
PRJNA254756,pIND_shMiz1.minusDox_BI8622,LS174T,pIND_shMiz1.minusDox_BI8622,10uM,NA,epithelial,large intestine; colon,Carcinoma,other
PRJNA254756,pIND_shMiz1.plusDox_BI8622,LS174T,pIND_shMiz1.plusDox_BI8622,10uM,NA,epithelial,large intestine; colon,Carcinoma,other
PRJNA254756,pLKO_empty.BI8622,LS174T,pLKO_empty.BI8622,10uM,NA,epithelial,large intestine; colon,Carcinoma,other
PRJNA254756,shHUWE1.BI8622,LS174T,shHUWE1.BI8622,10uM,NA,epithelial,large intestine; colon,Carcinoma,other
PRJNA474537,CC122.5,OSU-CLL,CC-122,0.1uM,5,EBV-transformed lymphoblastoid cell line,blood,Chronic lymphocytic leukemia,other
PRJNA474537,LEN.5,OSU-CLL,Lenalidomide,1uM,5,EBV-transformed lymphoblastoid cell line,blood,Chronic lymphocytic leukemia,other
PRJNA474537,CC122.24,OSU-CLL,CC-122,1uM,24,EBV-transformed lymphoblastoid cell line,blood,Chronic lymphocytic leukemia,other
PRJNA474537,LEN.24,OSU-CLL,Lenalidomide,1uM,24,EBV-transformed lymphoblastoid cell line,blood,Chronic lymphocytic leukemia,other
PRJNA352461,Azacitidine,BM MNC,Azacitidine,NA,NA,patient-derived AML,blood,Acute myeloid leukemia,other
PRJNA352461,LSD1i,BM MNC,LSD1i,NA,NA,patient-derived AML,blood,Acute myeloid leukemia,other
PRJNA352461,LSD1i_Azacitidine,BM MNC,LSD1i_Azacitidine,NA,NA,patient-derived AML,blood,Acute myeloid leukemia,other
PRJNA610784,Azacitidine,IDH1mut BM,Azacitidine,500nM,96,patient-derived AML,blood,Acute myeloid leukemia,other
PRJNA610784,BAY1436032,IDH1mut BM,BAY1436032,50nM,120,patient-derived AML,blood,Acute myeloid leukemia,other
PRJNA610784,BAY1436032_Azacitidine_seq,IDH1mut BM,BAY1436032_Azacitidine_seq,50nM+500nM,216,patient-derived AML,blood,Acute myeloid leukemia,other
PRJNA610784,BAY1436032_Azacitidine_sim,IDH1mut BM,BAY1436032_Azacitidine_sim,50nM+500nM,120,patient-derived AML,blood,Acute myeloid leukemia,other
